Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - thelancet.com
Background Pembrolizumab plus pemetrexed–platinum led to superior overall survival and
progression-free survival, and a higher proportion of patients with a confirmed complete or …
progression-free survival, and a higher proportion of patients with a confirmed complete or …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Pembrolizumab plus pemetrexed-platinum led to superior overall survival and
progression-free survival, and a higher proportion of patients with a confirmed complete or …
progression-free survival, and a higher proportion of patients with a confirmed complete or …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban… - The Lancet …, 2020 - accedacris.ulpgc.es
Pembrolizumab plus pemetrexedplatinum led to superior overall survival and progression-
free survival, and a higher proportion of patients with a confirmed complete or partial …
free survival, and a higher proportion of patients with a confirmed complete or partial …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - Elsevier
Background Pembrolizumab plus pemetrexed–platinum led to superior overall survival and
progression-free survival, and a higher proportion of patients with a confirmed complete or …
progression-free survival, and a higher proportion of patients with a confirmed complete or …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - thelancet.com
Background Pembrolizumab plus pemetrexed–platinum led to superior overall survival and
progression-free survival, and a higher proportion of patients with a confirmed complete or …
progression-free survival, and a higher proportion of patients with a confirmed complete or …
[PDF][PDF] Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous …
MC Garassino - lungfoundation.org.nz
Lung Cancer Page 1 Lung Cancer 1 Lung Cancer RESEARCH REVIEW™ Making Education
Easy www.researchreview.co.nz a RESEARCH REVIEW™ publication Welcome to this issue …
Easy www.researchreview.co.nz a RESEARCH REVIEW™ publication Welcome to this issue …
[引用][C] Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - cir.nii.ac.jp
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum
in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer …
in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - hub.hku.hk
Background: Pembrolizumab plus pemetrexed–platinum led to superior overall survival and
progression-free survival, and a higher proportion of patients with a confirmed complete or …
progression-free survival, and a higher proportion of patients with a confirmed complete or …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - europepmc.org
BACKGROUND: Pembrolizumab plus pemetrexed-platinum led to superior overall survival
and progression-free survival, and a higher proportion of patients with a confirmed complete …
and progression-free survival, and a higher proportion of patients with a confirmed complete …
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non …
MC Garassino, S Gadgeel, E Esteban, E Felip… - 2020 - wslhd.intersearch.com.au
BACKGROUND: Pembrolizumab plus pemetrexed-platinum led to superior overall survival
and progression-free survival, and a higher proportion of patients with a confirmed complete …
and progression-free survival, and a higher proportion of patients with a confirmed complete …